Skip to main content
Bjorn Oskarsson, MD, Neurology, Jacksonville, FL, Mayo Clinic Hospital in Florida

BjornE.OskarssonMDFAAN

Neurology Jacksonville, FL

Neuromuscular Medicine

Associate Professor of Neurology Consultant Neurology Director ALS Clinic Mayo Clinic Jacksonville

Dr. Oskarsson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Oskarsson's full profile

Already have an account?

Summary

  • I am a Neurologist working on clinical care of people with ALS and clinical research for better treatments of ALS for the future.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Neuromuscular Medicine (Neurology), 2004 - 2006
  • University of Colorado
    University of ColoradoResidency, Neurology, 2001 - 2004
  • University of Colorado
    University of ColoradoInternship, Internal Medicine, 2000 - 2001
  • Lund University Faculty of Medicine
    Lund University Faculty of MedicineClass of 1999

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - Present
  • FL State Medical License
    FL State Medical License 2016 - 2025
  • CO State Medical License
    CO State Medical License 2004 - 2009
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

  • Fellow American Academy of Neurology, 2016
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Poly(GR) Impairs Protein Translation and Stress Granule Dynamics in C9orf72-Associated Frontotemporal Dementia and Amyotrophic Lateral Sclerosis  
    Dennis W Dickson, Bjorn Oskarsson, Nature

Press Mentions

  • Toward Clinical Trials for One Type of ALS
    Toward Clinical Trials for One Type of ALSJanuary 2nd, 2019
  • Flex Pharma Investigates FLX-787 as Treatment for Cramps in ALS Patients
    Flex Pharma Investigates FLX-787 as Treatment for Cramps in ALS PatientsAugust 2nd, 2017
  • FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under IND
    FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under INDAugust 1st, 2017
  • Join now to see all

Professional Memberships

Other Languages

  • Swedish

Hospital Affiliations